Predictors of response to grazoprevir/elbasvir among HCV genotype 1 (GT1)–infected patients: integrated analysis of phase 2-3 trials [abstract 700]

Zeuzem S, Rockstroh JK, Kwo PY, et al. Predictors of response to grazoprevir/elbasvir among HCV genotype 1 (GT1)–infected patients: integrated analysis of phase 2-3 trials [abstract 700]. In Liver Meeting 2015. San Francisco, CA; 2015.

Publication Type:

Conference Paper

Authors:

Stefan Zeuzem; J K Rockstroh; P Y Kwo; et, al

Source:

Liver Meeting 2015, Number 700, San Francisco, CA (2015)

Cited On:

Export Citation:
RIS Format
Top